智通财经APP获悉，微创系集体走高，截至发稿，微创机器人-B(02252)涨22.06%，报18.7港元；微创医疗(00853)涨11.26%，报7.61港元；微创脑科学(02172)涨7.69%，报10.92港元；心通医疗-B(02160)涨7.41%，报0.87港元。
中信建投发布研报称，AI医疗在提升医疗器械功能、检查检验结果解读、辅助临床医生决策、健康管理等多个领域的应用价值巨大。AI技术不仅是医疗企业和医院必须重视的创新方向，也是未来竞争的关键趋势。国金证券指出，医疗设备借助AI辅助诊断软件，可在医生经验的基础上提高诊断的敏感性和特异性，以保障诊断的正确率，可以极大的降低医生的工作压力，增加工作效率，未来应用领域有望逐步拓宽。
花旗上月曾发布研报称，国务院办公厅印发《关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见》，明确5方面24条改革举措。该行认为多部门政策支持显示建立真正创新的重要性，提出“一企一策”显示政府及监管部门将对创新领导者分配资源，相信市场整合将加速，有利领先创新企业，包括微创医疗等。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.